Advertise on podcast: Macular Chats

Rating

★★★★★

4.8

from

12 reviews

Description

Macular Chats are a series of free, informative audio conversations hosted by Macular Degeneration Research, a BrightFocus Foundation program, featuring retina specialists and other eye care experts who will discuss various aspects of living with macular degeneration and geographic atrophy. Topics will include macular degeneration treatments, remaining independent, and promising research on the horizon. #Ophthalmology #Macular #MacularDegeneration #GeographicAtrophy #VisionLoss #LowVision

Podcast episodes

Check latest episodes from Macular Chats podcast

A New Drug Delivery Approach for Wet AMD

2026/09/30

Join us for a conversation with Daisy Shu, PhD, as she discusses her Macular Degeneration Research-funded project, New Drug Delivery Approach to Transform Macular Degeneration Treatment. Dr. Shu will share how new treatment approaches could make care easier for people with wet age-related macular degeneration by reducing the need for frequent eye injections while helping protect vision.

Eliminating Barriers to Care for People with Vision Loss

2026/08/26

Hear from Dr. April McCullough of Regeneron and Katherine Freund of Independent Transportation Network of America about the real-world barriers that prevent people with vision loss from accessing timely eye care. Together, they’ll explore how social determinants of health—specifically transportation—affect vision outcomes, and highlight innovative efforts such as Rides in Sight, a free national service helping connect people with reliable transportation to sight-saving medical appointments.

2026 Grants in Focus: Driving Breakthroughs in Macular Degeneration

2026/07/29

BrightFocus Foundation’s Macular Degeneration Research program is fueling the most promising scientific studies around the world to advance prevention, earlier detection, treatments, and ultimately a cure for macular degeneration. This year alone, we’ve invested $4.7 million in new funding for bold, forward-thinking research. In this session, learn about some of these pioneering projects and explore the exciting ideas shaping the future of vision research.

The Future of Age-Related Macular Degeneration and Geographic Atrophy: How Clinical Trials Are Paving the Way

2026/05/27

Clinical trials are essential to advancing care for age‑related macular degeneration (AMD) and geographic atrophy (GA). In this episode, Mathew MacCumber, MD, PhD, explains how clinical trials work, the potential benefits and challenges of participation, and key factors to consider when deciding whether a trial may be right for you. The discussion will also include a high-level overview of the GALLOP clinical trial for GA and what current research means for the future of vision health.

Cell Therapy and Macular Degeneration: Exploring a New Treatment Frontier

2026/04/29

Researchers are exploring whether cell therapy—including stem cells and stem cell–derived treatments—could help repair or replace damaged retinal cells in macular degeneration and geographic atrophy. In this episode, we explain how these therapies are intended to work, how the cells may be delivered to the eye, and the potential risks.

Podcast reviews

Read Macular Chats podcast reviews

4.8 out of 5

12 reviews

★★★★★

redwolfhopw 2024/12/26

Learning a lot!!

Really learning a lot. ——————————————————- unfortunately this is recorded at a very LOW volume as compared to other podcast. Your demographic might e...

★★★★★

AmyYangUSA 2022/08/26

interest all topic regarding dry & wet AMD

yes , interest all topic regarding dry & wet AMD . Really appreciate 🙏🙏🙏

★★★★☆

Drisky33 2021/08/05

Screening

Thanks for all the info. I was recently asked to take a screening test with a device called the AdaptDx Pro. I researched the MacuLogix website and it...

★★★★★

AdamDrow 2020/04/13

Concerned

Your chat on April 2 answered my decision not to go to appointment for my monthly injection, I had concerns for doing the right thing at my age, 80+ y...

check all reviews on apple podcasts